CoChat

Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone

Maurice Ferreri, Francis Lavergne, Ivan Berlin, Christine Payan, Alain Jacques Puech · 2001 · Acta Psychiatrica Scandinavica
Cited by 108

The DOI matches its OpenAlex record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To assess, in depressed patients, the clinical benefit of mianserin augmentation of fluoxetine or the the benefit of switching treatment from fluoxetine to mianserin. METHOD: In a 6-week double-blind study we compared the therapeutic efficiency and tolerance of mianserin 60 mg/day (N = 34), mianserin 60 mg/day plus fluoxetine 20 mg/day (N = 32) and continuing fluoxetine 20 mg/day (N = 38) in patients with major depression who did not respond to previous fluoxetine treatment. RESULTS: Intent-to-treat analysis showed that at week 6 the decrease in the Hamilton Depression rating scale score was significantly (P < or = 0.03) greater in the mianserin plus fluoxetine group when compared to the fluoxetine group (effect size 0.665). Switching from fluoxetine to mianserin gave intermediate results. Mianserin augmentation of fluoxetine was well tolerated. CONCLUSION: Mianserin augmentation of fluoxetine in patients non-responders to fluoxetine 20 mg/day increases response to treatment and is well tolerated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1034/j.1600-0447.2001.00148.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 24

  1. Debus JR, 1988, Fluoxetine versus trazodone in the treat‐ment of out‐patients with major depression, J Clin Psychiatry, 49, 422
  2. 10.1097/00004714-199310000-00002 · DOI · Paper page
  3. Tignol J, 1993, A double‐blind, randomized fluoxetine‐controlled, multicenter study of paroxetine in the treatment of depression, J Clin Psychopharmacol, 13, 18S, 10.1097/00004714-199312002-00003 · DOI · Paper page
  4. 10.1007/BF02245454 · DOI
  5. Bennie EH, 1995, A double blind multicenter trial comparing sertraline and fluoxetine in out‐patients with major depression, J Clin Psychiatry, 56, 229
  6. 10.1176/ajp.152.10.1500 · DOI · Paper page
  7. 10.1176/ajp.151.9.1372 · DOI · Paper page
  8. 10.1097/00004714-199904000-00014 · DOI
  9. 10.1055/s-2007-979298 · DOI · Paper page
  10. Klysner R, 1991, Refractory depression, 109
  11. Lafon‐Lopez L, 1986, Etude de la potentialisation de deux antidépresseurs entre eux. Clomipramine–miansérine. Evalu‐ation clinique et biologique. Actualités psychopharmacologiques, Inf Psychiatr, 9, 1147
  12. 10.1055/s-2007-1014403 · DOI
  13. 10.3109/08039489409081375 · DOI
  14. 10.1097/00002826-199706000-00004 · DOI · Paper page
  15. 10.1136/jnnp.23.1.56 · DOI · Paper page
  16. Ferreri M, 1984, Le diagramme HARD, Pratique Med, 33, 39
  17. Von Frenckell R, 1989, Validation factor‐ielle de l'échelle HARD dans deux groupes de déprimés, L'Encéphale, 15, 423
  18. 10.1001/archpsyc.1983.01790110077013 · DOI · Paper page
  19. 10.1192/bjp.162.5.634 · DOI · Paper page
  20. 10.1001/archpsyc.1993.01820170065008 · DOI · Paper page
  21. Koyama E, 1996, Identification of human cytochrome P 450 isoforms involved in the stereoselective metabolism of mianserin enantiomers, J Pharmacol Exp Ther, 278, 21, 10.1016/S0022-3565(25)20103-3 · doi:10.1016/s0022-3565(25)20103-3
  22. 10.1097/00008571-199710000-00005 · doi:10.1097/00008571-199710000-00005
  23. Schatzberg AF, 1997, Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation consensus panel, J Clin Psy-chiatry, 58, 5
  24. 10.1007/BF02245452 · DOI

Cited by

See all 108

Metadata

Authors
Ferreri, M., Lavergne, F., Berlin, I., Payan, C., & Puech, A. J.
Venue
Acta Psychiatrica Scandinavica
Publisher
Wiley
Published
2001-01
Volume
103
Issue
1
Pages
66-72
ISSN
  • 0001-690X (ISSN-L)
  • 1600-0447
OpenAlex
W1969153521
Cited by
108
References
2
FWCI
2.40
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone. https://app.cochat.ai/papers/10.1034/j.1600-0447.2001.00148.x
The paper
Ferreri, M., Lavergne, F., Berlin, I., Payan, C., & Puech, A. J. (2001). Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone. Acta Psychiatrica Scandinavica. https://doi.org/10.1034/j.1600-0447.2001.00148.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.